有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax
Chemical Name (8S)-7-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid 1-ethyl ester
CAS 83647-97-6
Related CAS 94841-17-5 (HCl)
Formula C22H30N2O5S2
Structure
Formula Weight 466.6228
Stage 上市-1995
Company Essex (Originator), Novartis (Originator), Schering-Plough (Originator), Pfizer (Licensee)
Activity/Mechanism CARDIOVASCULAR DRUGS, Hypertension, Treatment of, Angiotensin-I Converting Enzyme (ACE) Inhibitors
Syn. Route 4
Route 1
a new synthesis of spirapril has been described:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethanedithiol by means of boron trifluoride ethearate in glacial acetic acid gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is deprotected with hbr in acetic acid to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). this compound is then condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (iv) by means of n-hydroxysuccinimide (nos) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (dmcc) in dmf, or by means of n,n-disuccinimidyl carbonate and pyridine.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (iv)
Reference 1:
    swiss, g.f.; neustadt, b.r.; mcnamara, p.; baum, t.; smith, e.m.; gold, e.h.; sybertz, e.j.; angiotensin converting enzyme inhibitors: spirapril and related. j med chem 1989, 32, 7, 1600-6.

Route 2
a new synthesis of spirapril has been reported:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethandithiol by means of boron trifluoride ethearate in dichloromethane gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is treated with concentrated hcl to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). the protection of (iii) with tert-butoxycarbonyl chloride and with trimethylsilylethanol in the usual manner affords n-(tert-butoxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxyli c acid 2-(trimethylsilyl)ethyl ester (iv), which is condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (v) by a first treatment with p-toluenesulfonic acid and a condensation step with dicyclohexylcarbodiimide (dcc) and hydroxybenzotriazole (hbt), giving spirapril 2-(trimethylsilyl)ethyl ester (vi). finally, this ester is hydrolyzed with tetrabutylammonium fluoride trihydrate in dmf.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (v)
4-[(4-methoxyphenyl)sulfinyl]benzaldehyde (iv)
6-nitro-2,3-dihydro-4h-chromen-4-one (vi)
Reference 1:
    powell, j.r.; cushman, d.w.; krapcho, j.; turk, c.; deforrest, j.m.; spitzmiller, e.r.; karanewsky, d.s.; duggan, m.; rovnyak, g.; schwartz, j.; et al.; angiotensin-converting enzyme inhibitors. mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. j med chem 1988, 31, 6, 1148.

Route 3
the cyclization of 1-benzyloxycarbonyl-4-oxoproline methyl ester (i) with ethanedithiol (ii) by means of p-toluenesulfonic acid in refluxing acetic acid gives methyl 7-benzyloxycarbonyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iii), which is deprotected with 20% hbr to give methyl 1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iv). the condensation of (iv) with n-benzyloxycarbonyl alanine n-hydroxysuccinimide ester (v) affords the corresponding dipeptide methyl ester (vi), which is hydrolyzed with naoh to the free acid (vii), and deprotected with 20% hbr as before to 7-alanyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid (viii). finally, this compound is condensed with ethyl 2-oxo-4-phenylbutyrate (ix) by means of sodium cyanoborohydride in methanol.
List of intermediates No.
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
ethyl 3-bromo-4-hydroxy-5-iodobenzoate (i)
ethyl 3-bromo-4-(2-hydroxyethoxy)-5-iodobenzoate (ii)
3-chlorophenylboronic acid (a)
(iii)
(iv)
2,3,3a,4,5,6-hexahydro-1h-phenalen-1-one oxime (v)
(vi)
8-(7,8,9,9a-tetrahydro-1h-phenalen-3-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (vii)
(3r)-3-(palmitoyloxy)tetradecanoic acid (viii)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

Route 4
the condensation of (ix) with alanine benzyl ester (x) with sodium cyanoboohydride as before gives n-[1-(ethoxycarbonyl)-3-phenylpropyl]alanine benzyl ester (xi), which is submitted to fractional crystallization with maleic acid yielding n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine benzyl ester (xii), which is debenzylated by hydrogenation with h2 over pd/c in ethanol yielding the free acid (xiii). finally, this compound is condensed with spirane (iv) through the n-hydroxysuccinimide ester, in the usual way.
List of intermediates No.
1-(2-fluoro[1,1-biphenyl]-4-yl)-1-propanone (x)
(1s,2r)-2-phenylcyclohexanol (xiii)
2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-1h-pyrazol-3-yl]acetonitrile (xii)
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
methyl 1-methyl-5-nitro-1h-imidazol-2-yl sulfide; 1-methyl-2-(methylsulfanyl)-5-nitro-1h-imidazole (a)
(iv)
(1r)-1-(2-[[(4ar,6r,7r,8r,8as)-6-(benzyloxy)-8-hydroxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-yl]amino]-2-oxoethyl)dodecyl palmitate (xi)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名螺普利;英文名Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax;CAS[83647-97-6]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
华东地区己二酸市场小幅下行
黑龙江粗苯价格暂稳
PTA止跌在眼前
华东地区邻苯市场行情维稳
江西地区二氯甲烷价格暂稳
DOP价格继续下行
华东地区丁二烯市场价格盘整为主
华北地区邻苯市场行情暂稳
山东地区三氯甲烷价格
东北地区邻苯市场行情暂稳
山东地区粗苯价格暂稳
山东地区二氯甲烷市场价格下调
华东地区BDO市场平稳整理
华南地区己二酸行情弱势走低
江苏地区粗苯价格暂稳
浙江地区二氯甲烷价格下调
江苏地区二氯甲烷价格下调
华南地区BDO市场商谈出货
华北苯酐市场行情
华东地区BDO市场区间运行
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明